Related Experiment Videos
Arsenic trioxide and olanzapine co-administration: case analysis
Kenneth R Kaufman1, Saurabh Chhabra, Michael Levitt
1Department of Psychiatry, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. kaufmakr@umdnj.edu
Summary
Arsenic trioxide (ATO) for acute promyelocytic leukemia (APL) can prolong QTc. Olanzapine co-administration for psychiatric conditions appears safe, but monitoring for drug interactions is crucial.
Area of Science:
- Oncology
- Pharmacology
- Cardiology
Background:
- Arsenic trioxide (ATO) is a standard treatment for acute promyelocytic leukemia (APL).
- QTc prolongation is a known side effect of ATO, increasing cardiac risk.
- Co-administration of psychotropic medications with ATO requires careful consideration due to potential drug-drug interactions.
Observation:
- Olanzapine, a common psychotropic, was safely used alongside ATO in APL patients with comorbid psychiatric conditions.
- This suggests that some psychotropic-oncology agent combinations may be tolerable.
Findings:
- The co-administration of olanzapine with arsenic trioxide did not lead to significant observed adverse events in this context.
- Close monitoring for drug-drug interactions and cumulative effects is essential when combining oncology agents with psychotropics.
Implications:
- Further research is needed to establish the risk/benefit profiles for various psychotropic-ATO combinations.
- Reporting all instances of co-administration, both with and without adverse effects, is critical for building a comprehensive safety database.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...